enVVeno Medical Corp
NASDAQ:NVNO
Income Statement
Earnings Waterfall
enVVeno Medical Corp
Revenue
|
0
USD
|
Operating Expenses
|
-23.9m
USD
|
Operating Income
|
-23.9m
USD
|
Other Expenses
|
1.8m
USD
|
Net Income
|
-22.1m
USD
|
Income Statement
enVVeno Medical Corp
Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||
Revenue |
1
N/A
|
1
+5%
|
1
-33%
|
0
-24%
|
0
-33%
|
0
+14%
|
0
+3%
|
0
-42%
|
0
-5%
|
0
-44%
|
0
-40%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||||||||||||||||||||
Cost of Revenue |
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
(0)
N/A
|
0
N/A
|
0
-50%
|
0
N/A
|
0
N/A
|
0
+100%
|
0
+188%
|
0
-17%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||
Operating Expenses |
(3)
|
(5)
|
(5)
|
(6)
|
(6)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(17)
|
(19)
|
(24)
|
(27)
|
(25)
|
(26)
|
(26)
|
(25)
|
(25)
|
(24)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(11)
|
(14)
|
(16)
|
(18)
|
(15)
|
(14)
|
(13)
|
(12)
|
(11)
|
(11)
|
|
Research & Development |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(12)
|
(13)
|
(13)
|
(14)
|
(13)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
Operating Income |
(3)
N/A
|
(5)
-37%
|
(5)
-16%
|
(6)
-15%
|
(6)
-5%
|
(8)
-29%
|
(8)
+4%
|
(8)
+6%
|
(8)
-2%
|
(7)
+15%
|
(7)
-5%
|
(7)
-4%
|
(8)
-7%
|
(7)
+5%
|
(7)
-1%
|
(9)
-26%
|
(10)
-14%
|
(11)
-8%
|
(12)
-7%
|
(17)
-40%
|
(19)
-13%
|
(24)
-24%
|
(27)
-16%
|
(25)
+9%
|
(26)
-6%
|
(26)
+1%
|
(25)
+3%
|
(25)
+1%
|
(24)
+5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
2
|
2
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
(1)
|
(2)
|
(6)
|
(8)
|
(8)
|
(7)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(4)
N/A
|
(5)
-33%
|
(6)
-23%
|
(8)
-26%
|
(11)
-46%
|
(15)
-33%
|
(14)
+5%
|
(13)
+9%
|
(10)
+24%
|
(7)
+31%
|
(7)
-5%
|
(8)
-7%
|
(7)
+6%
|
(7)
+4%
|
(7)
-2%
|
(9)
-30%
|
(11)
-18%
|
(11)
-7%
|
(12)
-4%
|
(17)
-39%
|
(19)
-15%
|
(24)
-25%
|
(27)
-16%
|
(25)
+10%
|
(26)
-4%
|
(25)
+2%
|
(24)
+4%
|
(24)
+2%
|
(22)
+6%
|
|
Net Income | ||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(4)
|
(5)
|
(6)
|
(8)
|
(11)
|
(15)
|
(14)
|
(13)
|
(10)
|
(7)
|
(7)
|
(8)
|
(7)
|
(7)
|
(7)
|
(9)
|
(11)
|
(11)
|
(12)
|
(17)
|
(19)
|
(24)
|
(27)
|
(25)
|
(26)
|
(25)
|
(24)
|
(24)
|
(22)
|
|
Net Income (Common) |
(4)
N/A
|
(5)
-33%
|
(7)
-22%
|
(8)
-24%
|
(12)
-44%
|
(19)
-58%
|
(18)
+5%
|
(16)
+8%
|
(13)
+20%
|
(7)
+48%
|
(7)
-5%
|
(8)
-7%
|
(7)
+6%
|
(7)
+4%
|
(7)
-3%
|
(10)
-38%
|
(11)
-17%
|
(12)
-7%
|
(13)
-3%
|
(17)
-32%
|
(19)
-15%
|
(24)
-25%
|
(27)
-16%
|
(25)
+10%
|
(26)
-4%
|
(25)
+2%
|
(24)
+4%
|
(24)
+2%
|
(22)
+6%
|
|
EPS (Diluted) |
-9.05
N/A
|
-12.08
-33%
|
-14.75
-22%
|
-18.33
-24%
|
-26.36
-44%
|
-39.85
-51%
|
-37.93
+5%
|
-44.18
-16%
|
-26.63
+40%
|
-11.47
+57%
|
-9.87
+14%
|
-12.1
-23%
|
-9.74
+20%
|
-8.01
+18%
|
-4.88
+39%
|
-7.54
-55%
|
-1.97
+74%
|
-1.42
+28%
|
-1.36
+4%
|
-1.9
-40%
|
-1.69
+11%
|
-2.11
-25%
|
-2.44
-16%
|
-2.2
+10%
|
-2.29
-4%
|
-2.24
+2%
|
-2.15
+4%
|
-1.91
+11%
|
-1.37
+28%
|